STOCK TITAN

[Form 4] CELESTICA INC Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.

Celestica (CLS) ha riferito degli acquisti sul mercato aperto da parte di un amministratore il 30/10/2025. Il deposito riporta quattro operazioni di acquisto per un totale di 6.000 azioni ordinarie, a prezzi medi ponderati di 339,68 USD (700 azioni), 340,55 USD (600), 341,96 USD (3.227) e 342,44 USD (1.473). A seguito di tali operazioni, l'amministratore detiene direttamente 6.000 azioni, detenute direttamente. Non sono stati riportati strumenti derivati.

Celestica (CLS) informó sobre las compras en el mercado abierto de un director el 30/10/2025. La presentación enumera cuatro operaciones de compra por un total de 6.000 acciones ordinarias, a precios medios ponderados de 339,68 USD (700 acciones), 340,55 USD (600), 341,96 USD (3.227) y 342,44 USD (1.473). Después de estas operaciones, el director posee beneficiosamente 6.000 acciones, mantenidas directamente. No se reportaron valores derivados.

Celestica (CLS)는 2025년 10월 30일 이사회의 공개 매수에 대해 보고했습니다. 제출서는 총 6,000주의 보통주를 대상으로 한 네 건의 매수 거래를 나열하며 가중 평균 가격은 339.68달러(700주), 340.55달러(600주), 341.96달러(3,227주), 342.44달러(1,473주)입니다. 이 거래 이후 이사는 직접 6,000주를 보유합니다. 파생증권은 보고되지 않았습니다.

Celestica (CLS) a annoncé des achats sur le marché libre par un administrateur le 30/10/2025. Le dossier répertorie quatre transactions d'achat totalisant 6 000 actions ordinaires, à des prix moyens pondérés de 339,68 USD (700 actions), 340,55 USD (600), 341,96 USD (3 227) et 342,44 USD (1 473). À la suite de ces transactions, l’administrateur détient directement 6 000 actions. Aucun titre dérivé n’a été déclaré.

Celestica (CLS) meldete am 30.10.2025 offene Marktkäufe eines Directors. Die Einreichung listet vier Kauftransaktionen im Gesamtwert von 6.000 Stammaktien auf, zu gewichteten Durchschnittspreisen von 339,68 USD (700 Aktien), 340,55 USD (600), 341,96 USD (3.227) und 342,44 USD (1.473). Nach diesen Geschäften besitzt der Direktor direkt 6.000 Aktien. Keine Derivate wurden gemeldet.

Celestica (CLS) أبلغت عن عمليات شراء من قبل مدير في السوق المفتوحة بتاريخ 30/10/2025. تشير القوائم إلى أربع عمليات شراء بإجمالي 6,000 سهم عادي، بأسعار متوسطة وزنية قدرها 339.68 دولارًا (700 سهم)، 340.55 دولارًا (600)، 341.96 دولارًا (3,227)، و342.44 دولارًا (1,473). بعد هذه التداولات، يمتلك المدير فعليًا 6,000 سهم، مملوكة بشكل مباشر. لم تُذكر أدوات مشتقة.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Celestica (CLS) ha riferito degli acquisti sul mercato aperto da parte di un amministratore il 30/10/2025. Il deposito riporta quattro operazioni di acquisto per un totale di 6.000 azioni ordinarie, a prezzi medi ponderati di 339,68 USD (700 azioni), 340,55 USD (600), 341,96 USD (3.227) e 342,44 USD (1.473). A seguito di tali operazioni, l'amministratore detiene direttamente 6.000 azioni, detenute direttamente. Non sono stati riportati strumenti derivati.

Celestica (CLS) informó sobre las compras en el mercado abierto de un director el 30/10/2025. La presentación enumera cuatro operaciones de compra por un total de 6.000 acciones ordinarias, a precios medios ponderados de 339,68 USD (700 acciones), 340,55 USD (600), 341,96 USD (3.227) y 342,44 USD (1.473). Después de estas operaciones, el director posee beneficiosamente 6.000 acciones, mantenidas directamente. No se reportaron valores derivados.

Celestica (CLS)는 2025년 10월 30일 이사회의 공개 매수에 대해 보고했습니다. 제출서는 총 6,000주의 보통주를 대상으로 한 네 건의 매수 거래를 나열하며 가중 평균 가격은 339.68달러(700주), 340.55달러(600주), 341.96달러(3,227주), 342.44달러(1,473주)입니다. 이 거래 이후 이사는 직접 6,000주를 보유합니다. 파생증권은 보고되지 않았습니다.

Celestica (CLS) a annoncé des achats sur le marché libre par un administrateur le 30/10/2025. Le dossier répertorie quatre transactions d'achat totalisant 6 000 actions ordinaires, à des prix moyens pondérés de 339,68 USD (700 actions), 340,55 USD (600), 341,96 USD (3 227) et 342,44 USD (1 473). À la suite de ces transactions, l’administrateur détient directement 6 000 actions. Aucun titre dérivé n’a été déclaré.

Celestica (CLS) meldete am 30.10.2025 offene Marktkäufe eines Directors. Die Einreichung listet vier Kauftransaktionen im Gesamtwert von 6.000 Stammaktien auf, zu gewichteten Durchschnittspreisen von 339,68 USD (700 Aktien), 340,55 USD (600), 341,96 USD (3.227) und 342,44 USD (1.473). Nach diesen Geschäften besitzt der Direktor direkt 6.000 Aktien. Keine Derivate wurden gemeldet.

Celestica (CLS) أبلغت عن عمليات شراء من قبل مدير في السوق المفتوحة بتاريخ 30/10/2025. تشير القوائم إلى أربع عمليات شراء بإجمالي 6,000 سهم عادي، بأسعار متوسطة وزنية قدرها 339.68 دولارًا (700 سهم)، 340.55 دولارًا (600)، 341.96 دولارًا (3,227)، و342.44 دولارًا (1,473). بعد هذه التداولات، يمتلك المدير فعليًا 6,000 سهم، مملوكة بشكل مباشر. لم تُذكر أدوات مشتقة.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KOELLNER LAURETTE T

(Last) (First) (Middle)
5140 YONGE STREET
SUITE 1900

(Street)
TORONTO, A6 A6 M2N 6L7

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 10/30/2025 P 700 A $339.68(1) 700 D
Common Shares 10/30/2025 P 600 A $340.55(2) 1,300 D
Common Shares 10/30/2025 P 3,227 A $341.96(3) 4,527 D
Common Shares 10/30/2025 P 1,473 A $342.44(4) 6,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $339.27-$340.24, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $340.34-$340.72, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $341.35-$342.34, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $342.35-$342.64, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Samantha Graff, attorney-in-fact 10/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Celestica (CLS) report?

A director purchased 6,000 common shares in open‑market transactions on 10/30/2025.

How many trades and at what prices were the CLS shares bought?

Four purchases: 700 at $339.68, 600 at $340.55, 3,227 at $341.96, and 1,473 at $342.44.

What is the director’s beneficial ownership after the trades?

Beneficial ownership is 6,000 shares, held directly.

Were any derivative securities involved?

No. The filing reports no derivative securities.

What is the reporter’s relationship to Celestica (CLS)?

The reporting person is a Director of Celestica Inc.

Was this a single date of activity?

Yes. All reported purchases occurred on 10/30/2025.
Celestica

NYSE:CLS

CLS Rankings

CLS Latest News

CLS Latest SEC Filings

CLS Stock Data

39.13B
114.43M
0.52%
75.82%
4.35%
Electronic Components
Printed Circuit Boards
Link
Canada
TORONTO